Australia Publishes Plans For Global Regulatory Capacity Building
Executive Summary
Australia has outlined its plans for building up regulatory capacity and work-sharing among medicines agencies at the regional and global level in the next financial year.
You may also be interested in...
Janssen’s Apalutamide First To Gain Approval Under International Work Sharing Program
The ACSS Consortium’s work-sharing pilot for new drugs has yielded its first twin approval, for Janssen’s prostate cancer treatment, apalutamide.
Australia Says Yes To Using Assessments Reports From Key International Regulators
Prescription medicines could be approved faster in Australia after the Therapeutic Goods Administration issued an initial list of overseas agencies whose assessments reports it is prepared to rely on.
Industry Picks Holes In Australia’s Plans To Use Overseas Assessments
Industry believes that Australian proposals for speeding up drug registrations by using assessment reports from, or sharing work with, overseas regulators need a lot of fixes.